Orchid Island Capital Reports Strong Q3 2025 Results

By Bobby Samwell • Thursday, October 16 15:43 • Permanent Link

Orchid Island Capital, Inc. has released its estimated third quarter 2025 results, along with its October 2025 monthly dividend and the September 30, 2025 RMBS portfolio characteristics.

The estimated book value per share as of September 30, 2025, stands at $7.33, representing an increase from the previous period's book value per share. The estimated GAAP net income per share for the quarter ended September 30, 2025, is $0.53, which includes an estimated $0.37 per share of net realized and unrealized gains on RMBS and derivative instruments.

The estimated total return on equity for the quarter ended September 30, 2025, is 6.6%, indicating a positive performance compared to the previous period.

The company's RMBS portfolio characteristics as of September 30, 2025, are also presented, providing insights into the composition and risk measures of the portfolio.

Orchid Island Capital, Inc. has declared a monthly cash dividend of $0.12 per share of common stock, to be paid on November 26, 2025. This represents a continued commitment to making regular monthly cash distributions to its holders of common stock. As of October 15, 2025, the company had 151,712,160 shares of common stock outstanding, marking an increase from the prior period.

These figures and estimates are all preliminary, subject to change, and subject to review by the company’s independent registered public accounting firm. The company plans to announce its next common stock dividend on November 12, 2025.

The market has reacted to these announcements by moving the company's shares -0.14% to a price of $7.26. For the full picture, make sure to review Orchid Island Capital's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.